COMP <GO>
APUS vs CANF // ALTMAN Z-SCORE & DEBT/EQUITY
Apimeds Pharmaceuticals US Inc. (NYSE) VS. Can-Fite Biopharma Ltd each representing two (2) (NYSE) • 15-METRIC TALLY: APUS 2
— CANF 2
■ METRIC PARITY
LAST: $3.01 (-6.23%) • MKT CAP: $5.0M
balance-sheet
—
LAST: $1.62 (-2.41%) • MKT CAP: $5.0M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APUS VS. CANF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APUS | CANF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.20% | -35.00% | +28.80 | APUS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -39.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | CANF | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.7 | 28.2 | +16.50 | APUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.0M | $5.0M | -$80.5K | CANF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APUS REV | CANF REV | APUS GROSS % | CANF GROSS % | APUS FCF | CANF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $405.0K | — | — | -$9.0M | -$9.0M |
| FY 2024 | $0 | $674.0K | — | — | -$733.5K | -$7.6M |
| FY 2023 | $0 | $743.0K | — | — | -$627.8K | -$8.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APUS // BETA —
CANF // BETA —